This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
rsi: Archive
Alto Ingredients (ALTO) Loses -20.43% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Alto Ingredients (ALTO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ALTONegative Net Change
rsi stock-price-movement
Rapt Therapeutics (RAPT) Loses -47.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Rapt Therapeutics (RAPT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
RAPTPositive Net Change
rsi stock-price-movement
Down -64.16% in 4 Weeks, Here's Why AEON Biopharma, Inc. (AEON) Looks Ripe for a Turnaround
by Zacks Equity Research
AEON Biopharma, Inc. (AEON) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
AEONNegative Net Change
rsi stock-price-movement
Down -10.98% in 4 Weeks, Here's Why You Should You Buy the Dip in Centessa Pharmaceuticals (CNTA)
by Zacks Equity Research
Centessa Pharmaceuticals (CNTA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
CNTAPositive Net Change
rsi stock-price-movement
Freshwork (FRSH) Loses -28.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Freshwork (FRSH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
FRSHPositive Net Change
rsi stock-price-movement
Down -9.84% in 4 Weeks, Here's Why You Should You Buy the Dip in Magic Software (MGIC)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Magic Software (MGIC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
MGICPositive Net Change
rsi stock-price-movement
Down -38.41% in 4 Weeks, Here's Why AirSculpt Technologies (AIRS) Looks Ripe for a Turnaround
by Zacks Equity Research
AirSculpt Technologies (AIRS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
AIRSNegative Net Change
rsi stock-price-movement
Down -9.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Knife River (KNF)
by Zacks Equity Research
Knife River (KNF) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
KNFPositive Net Change
rsi stock-price-movement
Revance Therapeutics (RVNC) Loses -18.85% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Revance Therapeutics (RVNC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
RVNCPositive Net Change
rsi stock-price-movement
Down -11.49% in 4 Weeks, Here's Why Tennant (TNC) Looks Ripe for a Turnaround
by Zacks Equity Research
Tennant (TNC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
TNCNegative Net Change
rsi stock-price-movement
Here's Why CS Disco (LAW) is Poised for a Turnaround After Losing -17.49% in 4 Weeks
by Zacks Equity Research
The heavy selling pressure might have exhausted for CS Disco (LAW) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
LAWNo Net Change
rsi stock-price-movement
Down -12.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Talos Energy (TALO)
by Zacks Equity Research
Talos Energy (TALO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
TALOPositive Net Change
rsi stock-price-movement
Wabash (WNC) Loses -13.05% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Wabash (WNC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
WNCNegative Net Change
rsi stock-price-movement
Nice (NICE) Loses -10.58% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Nice (NICE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
NICENegative Net Change
rsi stock-price-movement
Down -5.51% in 4 Weeks, Here's Why AN2 Therapeutics (ANTX) Looks Ripe for a Turnaround
by Zacks Equity Research
AN2 Therapeutics (ANTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ANTXNegative Net Change
rsi stock-price-movement
After Plunging -19.89% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)
by Zacks Equity Research
Shattuck Labs (STTK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
STTKNegative Net Change
rsi stock-price-movement
KULR Technology Group (KULR) Loses -21.71% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
KULR Technology Group (KULR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
KULRNegative Net Change
rsi stock-price-movement
Down -6.19% in 4 Weeks, Here's Why ANI (ANIP) Looks Ripe for a Turnaround
by Zacks Equity Research
ANI (ANIP) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ANIPPositive Net Change
rsi stock-price-movement
Down -11.4% in 4 Weeks, Here's Why Wabash (WNC) Looks Ripe for a Turnaround
by Zacks Equity Research
Wabash (WNC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
WNCNegative Net Change
rsi stock-price-movement
Down -9.19% in 4 Weeks, Here's Why You Should You Buy the Dip in Align Technology (ALGN)
by Zacks Equity Research
Align Technology (ALGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ALGNNegative Net Change
rsi stock-price-movement
Annexon (ANNX) Loses -5.04% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Annexon (ANNX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ANNXPositive Net Change
rsi stock-price-movement
Here's Why Marinus Pharmaceuticals (MRNS) is Poised for a Turnaround After Losing -7.8% in 4 Weeks
by Zacks Equity Research
Marinus Pharmaceuticals (MRNS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
MRNSPositive Net Change
rsi stock-price-movement
Here's Why HCI Group (HCI) is Poised for a Turnaround After Losing -8.64% in 4 Weeks
by Zacks Equity Research
HCI Group (HCI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
HCIPositive Net Change
rsi stock-price-movement
Down -18.96% in 4 Weeks, Here's Why Veritone (VERI) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Veritone (VERI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
VERINegative Net Change
rsi stock-price-movement
Maplebear (CART) Loses -9.63% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Maplebear (CART) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
CARTNegative Net Change
rsi stock-price-movement